Effects of DaChengQi decoction on enteroparalysis and serum inflammatory cytokines in patients with severe acute p

Objective: The objective of this study was to investigate the effects of DaChengQi decoction (DCQD) on enteroparalysis and levels of the serum inflammatory cytokines CC motif chemokine ligand 2 (CCL2) and interleukin8 (IL8) in patients with severe acute pancreatitis (SAP). Methods: A total of 48 patients diagnosed with SAP who hospitalized in First Affiliated Hospital of Henan Traditional Chinese Medicine University from May 1, 2016 to May 30, 2018 were randomly assigned to the control or treatment groups. Patients in the control group (n=22) received conventional treatment and those in the treatment group (n=26) received conventional treatment as well as additional DCQD for 10 days. The duration of abdominal pain and distension, the time when bowel sounds returned to normal, changes in the levels of serum amylase, lipase, Creactive protein (CRP), CCL2 and IL8, as well as acute physiology and chronic health evaluation (APACHE) Ⅱ scores of patients on days 1 and 10 were recorded and compared. Results: The duration of abdominal pain and distension, the time when bowel sounds returned to normal, the levels of blood amylase, lipase and CRP, and APACHE Ⅱ scores of patients in the treatment group decreased significantly compared with those of patients in the control group. Though there were no statistical differences in serum CCL2 and IL8 concentrations on day 1 between patients in these two groups, the levels of serum CCL2 and IL8 in the treatment group were lower than those in the control group on day 10. Conclusion: DCQD may decrease the levels of CCL2, CRP, and IL8 in patients with SAP, quickly relieve enteroparalysis, and shorten hospitalization duration.